Inventor · disambiguated record
Chandravadan R. Shah
Also filed as: SHAH CHANDRAVADAN · SHAH CHANDRAVADAN R
36 granted patents·15 pending applications·172 citations·filing 2001–2023
97Inventor score
Files withJANSSEN PHARMACEUTICA NV17EPIGEN BIOSCIENCES INC7ORTHO MCNEIL PHARM INC7CARRUTHERS NICHOLAS I4CHAI WENYING3
Top patents by PatentIndex Score
51 records- 0194US11667644B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jun 6, 2023·2 cites·31 claims
- 0292US9079911B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jul 14, 2015·13 cites·17 claims
- 0392US8653263B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsCHAI WENYING·Filed 2010·Granted Feb 18, 2014·24 cites·30 claims
- 0491US7423147B2Pyridine compounds as histamine H3 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 9, 2008·17 cites·6 claims
- 0589US6803362B2Heterocyclic compoundsORTHO MCNEIL PHARM INC·Filed 2002·Granted Oct 12, 2004·38 cites·37 claims
- 0688US12378254B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Aug 5, 2025·0 cites·13 claims
- 0787US11059828B2Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·3 cites·21 claims
- 0885USRE48841EDisubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Dec 7, 2021·2 cites·37 claims
- 0985US6908929B2Phenyl-substituted imidazopyridinesORTHO MCNEIL PHARM INC·Filed 2001·Granted Jun 21, 2005·17 cites·21 claims
- 1084US8680275B2Fused heterocyclic compounds as orexin receptor modulatorsBRANSTETTER BRYAN JAMES·Filed 2010·Granted Mar 25, 2014·9 cites·20 claims
- 1184US7429659B2Furan compounds as histamine H3 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 30, 2008·7 cites·23 claims
- 1283US10570103B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2018·Granted Feb 25, 2020·3 cites·24 claims
- 1382US7947718B2Isoxazole compounds as histamine H3 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2009·Granted May 24, 2011·4 cites·24 claims
- 1482US7241778B2Non-imidazole aryloxypiperidinesORTHO MCNEIL PHARM INC·Filed 2005·Granted Jul 10, 2007·5 cites·16 claims
- 1578US7071191B2Non-imidazole aryloxypiperidinesORTHO MCNEIL PHARM INC·Filed 2001·Granted Jul 4, 2006·11 cites·17 claims
- 1676US7544698B2Indoles and benzoimidazoles as modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jun 9, 2009·2 cites·19 claims
- 1775US12234224B2Pyrimidine and pyridine amine compounds and usage thereof in disease treatmentEPIGEN BIOSCIENCES INC·Filed 2023·Granted Feb 25, 2025·0 cites·18 claims
- 1875US8642583B2Serotonin receptor modulatorsCARRUTHERS NICHOLAS I·Filed 2009·Granted Feb 4, 2014·2 cites·21 claims
- 1973US8183239B2Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptorBONAVENTURE PASCAL·Filed 2006·Granted May 22, 2012·2 cites·35 claims
- 2072US9062044B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsBRANSTETTER BRYAN JAMES·Filed 2010·Granted Jun 23, 2015·2 cites·18 claims
- 2170US7414047B2Piperazinyl and diazapanyl benzamides and benzthioamidesJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Aug 19, 2008·4 cites·26 claims
- 2268US7087757B2Phenyl-substituted imidazopyridinesORTHO MCNEIL PHARM INC·Filed 2004·Granted Aug 8, 2006·2 cites·3 claims
- 2367US11427552B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2020·Granted Aug 30, 2022·0 cites·20 claims
- 2466US7279491B2Phenylpiperidines and phenylpyrrolidinesJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Oct 9, 2007·2 cites·22 claims
- 2564US7041828B2Phenyl-substituted imidazopyridinesBREITENBUCHER J GUY·Filed 2004·Granted May 9, 2006·1 cites·4 claims
- 2664US2010004241A1Non-imidazole aryloxyalkylaminesAPODACA RICHARD·Filed 2009·Application pending·0 cites
- 2763US11866421B2Pyrimidine and pyridine amine compounds and usage thereof in disease treatmentEPIGEN BIOSCIENCES INC·Filed 2021·Granted Jan 9, 2024·0 cites·21 claims
- 2863US2017129901A1Disubstituted Octahydropyrrolo[3,4-C]Pyrroles As Orexin Receptor ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2963US2023286928A1Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3062US10526298B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2018·Granted Jan 7, 2020·0 cites·47 claims
- 3161US10000459B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2014·Granted Jun 19, 2018·0 cites·19 claims
- 3261US2008306085A1Non-imidazole aryloxyalkylaminesAPODACA RICHARD·Filed 2008·Application pending·0 cites
- 3361US2008306066A1Non-imidazole heterocyclic compoundsCARRUTHERS NICHOLAS I·Filed 2008·Application pending·0 cites
- 3459US7199117B2Phenyl-substituted imidazopyridinesORTHO MCNEIL PHARM INC·Filed 2004·Granted Apr 3, 2007·0 cites·9 claims
- 3559US7041827B2Phenyl-substituted imidazopyridinesBREITENBUCHER J GUY·Filed 2004·Granted May 9, 2006·0 cites·6 claims
- 3658US2015335651A1DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORSJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 3757US2008317671A1Non-imidazole heterocyclic compoundsCARRUTHERS NICHOLAS I·Filed 2008·Application pending·0 cites
- 3854US2014038943A1Serotonin receptor modulatorJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 3954US2008056991A1Piperazinyl and diazapanyl benzamides and benzthioamidesAPODACA RICHARD L·Filed 2007·Application pending·0 cites
- 4054US2008004314A1Phenylpiperidines and PhenylpyrrolidinesAPODACA RICHARD L·Filed 2007·Application pending·0 cites
- 4153US7429586B2Non-imidazole aryloxyalkylaminesORTHO MCNEIL PHARMACEUTICLAS I·Filed 2006·Granted Sep 30, 2008·0 cites·7 claims
- 4252US2005085487A1Heterocyclic compoundsFiled 2004·Application pending·0 cites
- 4351US9981909B2Serotonin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted May 29, 2018·0 cites·16 claims
- 4451US8236792B2Substituted pyrrolidine amides as modulators of the histamine H3 receptorCARRUTHERS NICHOLAS I·Filed 2009·Granted Aug 7, 2012·0 cites·40 claims
- 4551US7186732B2Non-imidazole aryloxyalkylaminesORTHO MCNEIL PHARM INC·Filed 2001·Granted Mar 6, 2007·0 cites·16 claims
- 4647US2012129870A1Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptorCHAI WENYING·Filed 2008·Application pending·0 cites
- 4747US2005049241A1Pyridyl piperazinyl ureasFiled 2004·Application pending·0 cites
- 4847US2012015957A1Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptorCHAI WENYING·Filed 2008·Application pending·0 cites
- 4945US7504426B2Heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Mar 17, 2009·0 cites·19 claims
- 5045US7417054B2Naphthyridine compoundsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 26, 2008·0 cites·34 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Chandravadan R. Shah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →